The proteins DHEA [54], tCECs [55], GABA [56], Thymidine glycol [57], Sarcosine [58], Fibronectin [60], Vitronectin [60], Spermine [61], circulating prostate microparticles [62], the element Selenium [59], and the panel PHI/rPSA/fPSA/TRAIL/IL-10 [63] were reported as biomarkers for PCa risk stratification. The gene discussed is FN1; the disease is posterior cortical atrophy.